Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - furosemide (frusemide) sodium -

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - furosemide (frusemide) -

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - furosemide (frusemide) -

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - furosemide (frusemide) -

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - furosemide, quantity: 20 mg - tablet - excipient ingredients: pregelatinised maize starch; magnesium stearate; lactose monohydrate; sodium starch glycollate type a; maize starch - oedema frusemide is indicated in adults, infants and children for the treatment of oedema associated with congestive heart failure, cirrhosis of the liver and renal disease including the nephrotic syndrome. frusemide is particularly useful when an agent with greater diuretic potential than that of those commonly employed is desired.,parenteral therapy with frusemide should be reserved for patients unable to take oral medication or for patients in emergency clinical situations. if gastrointestinal absorption is impaired or oral medication is not practical for any reason, frusemide is indicated by the intravenous or intramuscular route. parenteral use should be replaced with oral frusemide as soon as practical.,hypertension oral frusemide may be used in adults for the treatment of hypertension alone or in combination with other antihypertensive agents. hypertensive patients who cannot be adequately controlled with thiazides will probably also not be adequately controlled with frusemide alone.

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - furosemide, quantity: 40 mg - tablet - excipient ingredients: maize starch; sodium starch glycollate type a; lactose monohydrate; pregelatinised maize starch; magnesium stearate - oedema frusemide is indicated in adults, infants and children for the treatment of oedema associated with congestive heart failure, cirrhosis of the liver and renal disease including the nephrotic syndrome. frusemide is particularly useful when an agent with greater diuretic potential than that of those commonly employed is desired.,parenteral therapy with frusemide should be reserved for patients unable to take oral medication or for patients in emergency clinical situations. if gastrointestinal absorption is impaired or oral medication is not practical for any reason, frusemide is indicated by the intravenous or intramuscular route. parenteral use should be replaced with oral frusemide as soon as practical.,hypertension oral frusemide may be used in adults for the treatment of hypertension alone or in combination with other antihypertensive agents. hypertensive patients who cannot be adequately controlled with thiazides will probably also not be adequately controlled with frusemide alone.

Kenya - angol - Pharmacy and Poisons Board

gracure pharmaceuticals ltd e-1105 riico lndustrialarea phase-lll bhiwadi - frusemide - tablet - frusemide 40mg - high-ceiling diuretics: plain sulfonamides

Kenya - angol - Pharmacy and Poisons Board

biodeal laboratories ltd p.o. box 32040 nairoki kenya - frusemide - tablet - frusemide 40mg - high-ceiling diuretics: plain sulfonamides

Kenya - angol - Pharmacy and Poisons Board

questa care inc. c/o surgilinks ltd questa care inc. 4251 s. higuera st. suite 800 - frusemide bp - injection - frusemide bp 10mg/2ml - high-ceiling diuretics: plain sulfonamides

Kenya - angol - Pharmacy and Poisons Board

dawa limited p.o box 16633-00620 nairobi kenya - frusemide - injection - frusemide bp 10mg/ml - high-ceiling diuretics: plain sulfonamides